Active Pharmaceutical Ingredients CDMO Market is expected to expand at a CAGR of 6.7% from 2021 to 2028.
Active Pharmaceutical Ingredients CDMO Industry Overview The global active pharmaceutical ingredients CDMO market size was estimated at USD 81.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.7% from 2021 to 2028. The growth can be attributed to factors such as increased drug R&D, the rising incidence of chronic diseases, the expanding importance of generics, and the increasing consumption of biopharmaceuticals. Pharma companies have been increasing the amount of discovery, development, and manufacturing work they outsource over the last couple of decades. However, the urge to outsource is not uniform in the biopharma industry. Small biotechnology companies frequently rely on a Contract Development and Manufacturing Organization (CDMO) to produce their development products as they go through the pipeline. Gather more insights about the market drivers, restrains and growth of the Global Active Pharmaceut...